Haemonetics Stock Technical Analysis

HAE Stock  USD 83.62  2.38  2.93%   
As of the 23rd of April, Haemonetics retains the Market Risk Adjusted Performance of 0.0159, downside deviation of 1.96, and Risk Adjusted Performance of 0.0127. Haemonetics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Haemonetics, which can be compared to its competitors. Please check out Haemonetics information ratio, value at risk, and the relationship between the standard deviation and treynor ratio to decide if Haemonetics is priced fairly, providing market reflects its last-minute price of 83.62 per share. Given that Haemonetics has jensen alpha of (0.1), we strongly advise you to confirm Haemonetics's regular market performance to make sure the company can sustain itself at a future point.

Haemonetics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Haemonetics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Haemonetics
  
Haemonetics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Haemonetics Analyst Consensus

Target PriceAdvice# of Analysts
107.29Buy7Odds
Haemonetics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Haemonetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Haemonetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Haemonetics, talking to its executives and customers, or listening to Haemonetics conference calls.
Haemonetics Analyst Advice Details
Haemonetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Haemonetics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Haemonetics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Haemonetics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Haemonetics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Haemonetics Trend Analysis

Use this graph to draw trend lines for Haemonetics. You can use it to identify possible trend reversals for Haemonetics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Haemonetics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Haemonetics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Haemonetics applied against its price change over selected period. The best fit line has a slop of   0.19  , which may imply that Haemonetics will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 1365.55, which is the sum of squared deviations for the predicted Haemonetics price change compared to its average price change.

About Haemonetics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Haemonetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Haemonetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Haemonetics price pattern first instead of the macroeconomic environment surrounding Haemonetics. By analyzing Haemonetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Haemonetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Haemonetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.0085930.006123
Price To Sales Ratio4.272.14

Haemonetics April 23, 2024 Technical Indicators

Most technical analysis of Haemonetics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Haemonetics from various momentum indicators to cycle indicators. When you analyze Haemonetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haemonetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.
Note that the Haemonetics information on this page should be used as a complementary analysis to other Haemonetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Haemonetics Stock analysis

When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Haemonetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Earnings Share
2.46
Revenue Per Share
25.092
Quarterly Revenue Growth
0.101
Return On Assets
0.0612
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.